ADXN Q1 2024 Earnings Biotech Reports Net Loss Amid Clinical Pipeline Progress VABK Q1 2026 Earnings EPS of 097 Reported Amid Modest Stock Decline Accuray ARAY Q1 2026 Earnings EPS Misses Estimates as Revenue Figures Remain Unreported NGL Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement NEUP Q1 2026 Earnings WiderThanExpected Loss Narrows Sharply as Clinical Pipeline Progress Drives Investor Optimism CTRI Q1 2026 Earnings NarrowerThanExpected Loss Drives Positive Surprise